BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Muggeo P, Calore E, Decembrino N, Frenos S, De Leonardis F, Colombini A, Petruzziello F, Perruccio K, Berger M, Burnelli R, Zanazzo GA, Santoro N, Cesaro S. Invasive mucormycosis in children with cancer: A retrospective study from the Infection Working Group of Italian Pediatric Hematology Oncology Association. Mycoses. 2019;62:165-170. [PMID: 30338581 DOI: 10.1111/myc.12862] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Decembrino N, Perruccio K, Zecca M, Colombini A, Calore E, Muggeo P, Soncini E, Comelli A, Molinaro M, Goffredo BM, De Gregori S, Giardini I, Scudeller L, Cesaro S. A Case Series and Literature Review of Isavuconazole Use in Pediatric Patients with Hemato-oncologic Diseases and Hematopoietic Stem Cell Transplantation. Antimicrob Agents Chemother 2020;64:e01783-19. [PMID: 31871077 DOI: 10.1128/AAC.01783-19] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 11.0] [Reference Citation Analysis]
2 Ashkenazi-Hoffnung L, Bilavsky E, Levy I, Grisaru G, Sadot E, Ben-Ami R, Novikov A, Fischer S, Nahum E, Scheuerman O. Isavuconazole As Successful Salvage Therapy for Mucormycosis in Pediatric Patients. Pediatr Infect Dis J 2020;39:718-24. [PMID: 32251256 DOI: 10.1097/INF.0000000000002671] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
3 Chikley A, Ben-Ami R, Kontoyiannis DP. Mucormycosis of the Central Nervous System. J Fungi (Basel) 2019;5:E59. [PMID: 31288475 DOI: 10.3390/jof5030059] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
4 Biddeci G, Antonello M, Pizzi M, Petris MG, Pillon M, Donà D, Biffi A, Putti MC. Mucormycosis with peculiar aortic involvement in a child with acute lymphoblastic leukemia. Pediatr Hematol Oncol 2020;37:164-9. [PMID: 31847684 DOI: 10.1080/08880018.2019.1691294] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Avatef Fazeli M, Rezaei L, Javadirad E, Iranfar K, Khosravi A, Amini Saman J, Poursabbagh P, Ghadami MR, Parandin MM, Dehghani A, Ahmadi Jouybari T, Mahdavian B, Eivazi N, Rezaei S, Rezaei A, Emami B, Haqgou M, Bozorgomid A, Sayad B. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study. Mycoses 2021. [PMID: 34252988 DOI: 10.1111/myc.13351] [Reference Citation Analysis]
6 Elitzur S, Arad-Cohen N, Barg A, Litichever N, Bielorai B, Elhasid R, Fischer S, Fruchtman Y, Gilad G, Kapelushnik J, Kharit M, Konen O, Laor R, Levy I, Raviv D, Shachor-Meyouhas Y, Shvartser-Beryozkin Y, Toren A, Yaniv I, Nirel R, Izraeli S, Barzilai-Birenboim S. Mucormycosis in children with haematological malignancies is a salvageable disease: a report from the Israeli Study Group of Childhood Leukemia. Br J Haematol 2020;189:339-50. [PMID: 31885080 DOI: 10.1111/bjh.16329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
7 Feng Y, Guo W, Wang Y, Shi W, Liu C, Li D, Qiu Y, Shi D. Rhinocerebral mucormycosis caused by Rhizopus oryzae in a patient with acute myeloid leukemia: A case report. WJD 2020;8:1-9. [DOI: 10.5314/wjd.v8.i1.1] [Reference Citation Analysis]